Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

An evaluation of the effect of bortezomib on radiation-induced urinary bladder dysfunction.

Sarsarshahi S, Madjd Z, Bozsaky E, Kowaliuk J, Kuess P, Ghahremani MH, Doerr W.

Strahlenther Onkol. 2019 Jul 30. doi: 10.1007/s00066-019-01497-8. [Epub ahead of print]

PMID:
31363801
2.

Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.

Kalantari E, Abolhasani M, Roudi R, Farajollahi MM, Farhad S, Madjd Z, Askarian-Amiri S, Mohsenzadegan M.

Int J Exp Pathol. 2019 Apr;100(2):123-132. doi: 10.1111/iep.12314. Epub 2019 May 14.

PMID:
31090157
3.

High GD2 expression defines breast cancer cells with enhanced invasiveness.

Mansoori M, Roudi R, Abbasi A, Abolhasani M, Abdi Rad I, Shariftabrizi A, Madjd Z.

Exp Mol Pathol. 2019 Aug;109:25-35. doi: 10.1016/j.yexmp.2019.05.001. Epub 2019 May 8.

PMID:
31075227
4.

Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas.

Shafiei S, Kalantari E, Saeednejad Zanjani L, Abolhasani M, Asadi Lari MH, Madjd Z.

Exp Mol Pathol. 2019 Jun;108:164-172. doi: 10.1016/j.yexmp.2019.04.015. Epub 2019 Apr 25.

PMID:
31028726
5.

CD44 epithelial isoform inversely associates with invasive characteristics of colorectal cancer.

Sadeghi A, Roudi R, Mirzaei A, Zare Mirzaei A, Madjd Z, Abolhasani M.

Biomark Med. 2019 Apr;13(6):419-426. doi: 10.2217/bmm-2018-0337. Epub 2019 Apr 3.

6.

Induction of miR-31 causes increased sensitivity to 5-FU and decreased migration and cell invasion in gastric adenocarcinoma.

Korourian A, Madjd Z, Roudi R, Shariftabrizi A, Soleimani M.

Bratisl Lek Listy. 2019;120(1):35-39. doi: 10.4149/BLL_2019_005.

PMID:
30685990
7.

In Vitro Cytotoxicity of Folate-Silica-Gold Nanorods on Mouse Acute Lymphoblastic Leukemia and Spermatogonial Cells.

Eslahi N, Shakeri-Zadeh A, Ashtari K, Pirhajati-Mahabadi V, Tohidi Moghadam T, Shabani R, Kamrava K, Madjd Z, Maki C, Asgari HR, Koruji M.

Cell J. 2019 Apr;21(1):14-26. doi: 10.22074/cellj.2019.5691. Epub 2018 Nov 18.

8.

Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma.

Saeednejad Zanjani L, Madjd Z, Abolhasani M, Rasti A, Shariftabrizi A, Mehrazma M, Fodstad Ø, Asgari M.

Pathology. 2019 Jan;51(1):21-31. doi: 10.1016/j.pathol.2018.08.019. Epub 2018 Nov 19.

PMID:
30466948
9.

Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.

Rasti A, Mehrazma M, Madjd Z, Abolhasani M, Saeednejad Zanjani L, Asgari M.

Sci Rep. 2018 Aug 6;8(1):11739. doi: 10.1038/s41598-018-30168-4.

10.

3D Protein-Based Bilayer Artificial Skin for the Guided Scarless Healing of Third-Degree Burn Wounds in Vivo.

Gholipourmalekabadi M, Seifalian AM, Urbanska AM, Omrani MD, Hardy JG, Madjd Z, Hashemi SM, Ghanbarian H, Brouki Milan P, Mozafari M, Reis RL, Kundu SC, Samadikuchaksaraei A.

Biomacromolecules. 2018 Jul 9;19(7):2409-2422. doi: 10.1021/acs.biomac.7b01807. Epub 2018 Apr 18.

PMID:
29529861
11.

Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.

Saeednejad Zanjani L, Madjd Z, Abolhasani M, Shariftabrizi A, Rasti A, Asgari M.

Cancer Biomark. 2018;21(4):821-837. doi: 10.3233/CBM-170755.

PMID:
29286924
12.

Circulating cancer stem cell markers in breast carcinomas: a systematic review protocol.

Mansoori M, Madjd Z, Janani L, Rasti A.

Syst Rev. 2017 Dec 19;6(1):262. doi: 10.1186/s13643-017-0660-y.

13.

Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma.

Zanjani LS, Madjd Z, Abolhasani M, Rasti A, Fodstad O, Andersson Y, Asgari M.

Biomark Med. 2018 Jan;12(1):45-61. doi: 10.2217/bmm-2017-0142. Epub 2017 Dec 15.

PMID:
29243496
14.

Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.

Rasti A, Madjd Z, Abolhasani M, Mehrazma M, Janani L, Saeednejad Zanjani L, Asgari M.

Clin Exp Med. 2018 May;18(2):177-190. doi: 10.1007/s10238-017-0481-2. Epub 2017 Dec 4.

PMID:
29204790
15.

Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.

Gheytanchi E, Madjd Z, Janani L, Rasti A, Ghods R, Atyabi F, Asadi-Lari MH, Babashah S.

Syst Rev. 2017 Nov 17;6(1):228. doi: 10.1186/s13643-017-0624-2.

16.

Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.

Saeednejad Zanjani L, Madjd Z, Abolhasani M, Andersson Y, Rasti A, Shariftabrizi A, Asgari M.

Exp Mol Pathol. 2017 Oct;103(2):218-228. doi: 10.1016/j.yexmp.2017.10.001. Epub 2017 Oct 16.

PMID:
29050853
17.

Lgr5High/DCLK1High phenotype is more common in early stage and intestinal subtypes of gastric carcinomas.

Kalantari E, Asadi Lari MH, Roudi R, Korourian A, Madjd Z.

Cancer Biomark. 2017 Dec 6;20(4):563-573. doi: 10.3233/CBM-170383.

PMID:
28946555
18.

MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.

Korourian A, Roudi R, Shariftabrizi A, Madjd Z.

Exp Biol Med (Maywood). 2017 Dec;242(18):1842-1847. doi: 10.1177/1535370217728460. Epub 2017 Aug 24.

19.

A Simple, Rapid, and Efficient Method for Isolating Mesenchymal Stem Cells from the Entire Umbilical Cord.

Dehkordi MB, Madjd Z, Chaleshtori MH, Meshkani R, Nikfarjam L, Kajbafzadeh AM.

Cell Transplant. 2016 Jul;25(7):1287-1297. doi: 10.3727/096368915X582769.

PMID:
28836831
20.

Cancer stem cell research in Iran: potentials and challenges.

Roudi R, Ebrahimi M, Shariftabrizi A, Madjd Z.

Future Oncol. 2017 Aug;13(20):1809-1826. doi: 10.2217/fon-2017-0091. Epub 2017 Aug 4. Review.

PMID:
28776391
21.

Possible involvement of CREB/BDNF signaling pathway in neuroprotective effects of topiramate against methylphenidate induced apoptosis, oxidative stress and inflammation in isolated hippocampus of rats: Molecular, biochemical and histological evidences.

Motaghinejad M, Motevalian M, Babalouei F, Abdollahi M, Heidari M, Madjd Z.

Brain Res Bull. 2017 Jun;132:82-98. doi: 10.1016/j.brainresbull.2017.05.011. Epub 2017 May 24.

PMID:
28552672
22.

Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas.

Kalantari E, Asgari M, Nikpanah S, Salarieh N, Asadi Lari MH, Madjd Z.

Pathol Oncol Res. 2017 Oct;23(4):793-802. doi: 10.1007/s12253-016-0169-z. Epub 2017 Jan 12.

PMID:
28083789
23.

Topiramate Confers Neuroprotection Against Methylphenidate-Induced Neurodegeneration in Dentate Gyrus and CA1 Regions of Hippocampus via CREB/BDNF Pathway in Rats.

Motaghinejad M, Motevalian M, Abdollahi M, Heidari M, Madjd Z.

Neurotox Res. 2017 Apr;31(3):373-399. doi: 10.1007/s12640-016-9695-4. Epub 2017 Jan 11.

PMID:
28078543
24.

Differential role of Wnt signaling and base excision repair pathways in gastric adenocarcinoma aggressiveness.

Korourian A, Roudi R, Shariftabrizi A, Kalantari E, Sotoodeh K, Madjd Z.

Clin Exp Med. 2017 Nov;17(4):505-517. doi: 10.1007/s10238-016-0443-0. Epub 2016 Dec 1.

PMID:
27909884
25.

Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methods.

Mirzaei A, Madjd Z, Kadijani AA, Tavakoli-Yaraki M, Modarresi MH, Verdi J, Akbari A, Tavoosidana G.

Cancer Biomark. 2016 Sep 26;17(3):301-311.

PMID:
27802206
26.

Coenzyme Q10 Ameliorates Trimethyltin Chloride Neurotoxicity in Experimental Model of Injury in Dentate Gyrus of Hippocampus: A Histopathological and Behavioral Study.

Sakhaie MH, Soleimani M, Pirhajati V, Soleimani Asl S, Madjd Z, Mehdizadeh M.

Iran Red Crescent Med J. 2016 Jun 8;18(8):e30297. eCollection 2016 Aug.

27.

Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.

Roudi R, Madjd Z, Ebrahimi M, Najafi A, Korourian A, Shariftabrizi A, Samadikuchaksaraei A.

Tumour Biol. 2016 Sep;37(9):11843-11859. Epub 2016 Apr 5.

PMID:
27048287
28.

Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma.

Rasti A, Abolhasani M, Zanjani LS, Asgari M, Mehrazma M, Madjd Z.

J Cancer Res Clin Oncol. 2017 Jan;143(1):95-104. doi: 10.1007/s00432-016-2239-8. Epub 2016 Sep 16.

PMID:
27638770
29.

Evaluation of anaplastic lymphoma kinase expression in nonsmall cell lung cancer;a tissue microarray analysis.

Roudi R, Haji G, Madjd Z, Shariftabrizi A, Mehrazma M.

J Cancer Res Ther. 2016 Apr-Jun;12(2):1065-9. doi: 10.4103/0973-1482.170940. Erratum in: J Cancer Res Ther. 2016 Jul-Sep;12 (3):1209.

30.

Probiotic feeding affects T cell populations in blood and lymphoid organs in chickens.

Asgari F, Madjd Z, Falak R, Bahar MA, Nasrabadi MH, Raiani M, Shekarabi M.

Benef Microbes. 2016 Nov 30;7(5):669-675. Epub 2016 Jun 28.

PMID:
27349931
31.

Impaired Memory and Evidence of Histopathology in CA1 Pyramidal Neurons through Injection of Aβ1-42 Peptides into the Frontal Cortices of Rat.

Eslamizade MJ, Madjd Z, Rasoolijazi H, Saffarzadeh F, Pirhajati V, Aligholi H, Janahmadi M, Mehdizadeh M.

Basic Clin Neurosci. 2016 Jan;7(1):31-41.

32.

Expression of CD133 cancer stem cell marker in melanoma: a systematic review and meta-analysis.

Madjd Z, Erfani E, Gheytanchi E, Moradi-Lakeh M, Shariftabrizi A, Asadi-Lari M.

Int J Biol Markers. 2016 May 28;31(2):e118-25. doi: 10.5301/jbm.5000209. Review.

PMID:
27102864
33.

Expression of Cancer Stem Cell Markers OCT4 and CD133 in Transitional Cell Carcinomas.

Sedaghat S, Gheytanchi E, Asgari M, Roudi R, Keymoosi H, Madjd Z.

Appl Immunohistochem Mol Morphol. 2017 Mar;25(3):196-202. doi: 10.1097/PAI.0000000000000291.

PMID:
26945449
35.

Increased Expression of ALDH1A1 in Prostate Cancer is Correlated With Tumor Aggressiveness: A Tissue Microarray Study of Iranian Patients.

Kalantari E, Saadi FH, Asgari M, Shariftabrizi A, Roudi R, Madjd Z.

Appl Immunohistochem Mol Morphol. 2017 Sep;25(8):592-598. doi: 10.1097/PAI.0000000000000343.

PMID:
26894647
36.

Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol.

Rasti A, Mehrazma M, Madjd Z, Keshtkar AA, Roudi R, Babashah S.

BMJ Open. 2016 Jan 4;6(1):e009667. doi: 10.1136/bmjopen-2015-009667.

37.

Comparative expression analysis of putative cancer stem cell markers CD44 and ALDH1A1 in various skin cancer subtypes.

Erfani E, Roudi R, Rakhshan A, Sabet MN, Shariftabrizi A, Madjd Z.

Int J Biol Markers. 2016 Feb 29;31(1):e53-61. doi: 10.5301/jbm.5000165.

PMID:
26391478
38.

A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?

Mirzaei A, Tavoosidana G, Rad AA, Rezaei F, Tavakoli-Yaraki M, Kadijani AA, Khalili E, Madjd Z.

Tumour Biol. 2016 Feb;37(2):2405-14. doi: 10.1007/s13277-015-3989-7. Epub 2015 Sep 17.

PMID:
26383518
39.

Comparative gene-expression profiling of CD133(+) and CD133(-) D10 melanoma cells.

Roudi R, Ebrahimi M, Sabet MN, Najafi A, Nourani MR, Fomeshi MR, Samadikuchaksaraei A, Shariftabrizi A, Madjd Z.

Future Oncol. 2015;11(17):2383-93. doi: 10.2217/fon.15.174. Epub 2015 Aug 19.

PMID:
26285774
40.

A Simple, Rapid, and Efficient Method for Isolating Mesenchymal Stem Cells From the Entire Umbilical Cord.

Banitalebi Dehkordi M, Madjd Z, Chaleshtori MH, Meshkani R, Nikfarjam L, Kajbafzadeh AM.

Cell Transplant. 2016;25(7):1287-97. doi: 10.3727/096368915X688911. Epub 2015 Aug 12.

PMID:
26270183
41.

PI3K/Akt inhibition and down-regulation of BCRP re-sensitize MCF7 breast cancer cell line to mitoxantrone chemotherapy.

Komeili-Movahhed T, Fouladdel S, Barzegar E, Atashpour S, Hossein Ghahremani M, Nasser Ostad S, Madjd Z, Azizi E.

Iran J Basic Med Sci. 2015 May;18(5):472-7.

42.

Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.

Roudi R, Korourian A, Shariftabrizi A, Madjd Z.

Cancer Invest. 2015;33(7):294-302. doi: 10.3109/07357907.2015.1034869. Epub 2015 Jun 5.

PMID:
26046383
43.

Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy.

Mohsenzadegan M, Tajik N, Madjd Z, Shekarabi M, Farajollahi MM.

Med J Islam Repub Iran. 2015 Jan 13;29:159. eCollection 2015.

44.

Study of NGEP expression pattern in cancerous tissues provides novel insights into prognostic marker in prostate cancer.

Mohsenzadegan M, Shekarabi M, Madjd Z, Asgari M, Abolhasani M, Tajik N, Farajollahi MM.

Biomark Med. 2015;9(4):391-401. doi: 10.2217/bmm.14.106.

PMID:
25808443
45.

A comparative study of mesenchymal stem cell transplantation with its paracrine effect on control of hyperglycemia in type 1 diabetic rats.

Aali E, Mirzamohammadi S, Ghaznavi H, Madjd Z, Larijani B, Rayegan S, Sharifi AM.

J Diabetes Metab Disord. 2014 Aug 11;13(1):76. doi: 10.1186/2251-6581-13-76. eCollection 2014.

46.

Effect of Copper Sulfate on Expression of Endogenous L1 Retrotransposons in HepG2 Cells (Hepatocellular Carcinoma).

Karimi A, Majidzadeh-A K, Madjd Z, Akbari A, Habibi L, Akrami SM.

Biol Trace Elem Res. 2015 Jun;165(2):131-4. doi: 10.1007/s12011-015-0256-0. Epub 2015 Feb 8.

PMID:
25663478
47.

Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.

Mirzaei A, Tavoosidana G, Modarressi MH, Rad AA, Fazeli MS, Shirkoohi R, Tavakoli-Yaraki M, Madjd Z.

Tumour Biol. 2015 Jun;36(6):4801-10. doi: 10.1007/s13277-015-3132-9. Epub 2015 Jan 29.

PMID:
25631749
48.

Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.

Sabet MN, Rakhshan A, Erfani E, Madjd Z.

Asian Pac J Cancer Prev. 2014;15(19):8161-9.

49.

Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer.

Roudi R, Madjd Z, Korourian A, Mehrazma M, Molanae S, Sabet MN, Shariftabrizi A.

Cancer Biomark. 2014;14(6):457-67. doi: 10.3233/CBM-140424.

PMID:
25335738
50.

High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma.

Ghods R, Ghahremani MH, Madjd Z, Asgari M, Abolhasani M, Tavasoli S, Mahmoudi AR, Darzi M, Pasalar P, Jeddi-Tehrani M, Zarnani AH.

Cancer Immunol Immunother. 2014 Dec;63(12):1319-27. doi: 10.1007/s00262-014-1594-z. Epub 2014 Sep 4.

PMID:
25186610

Supplemental Content

Support Center